David Goldfarb, M.D.
| Appointed: |
1992 |
| Gender: |
Male |
| Languages: |
English |
Urology
Transplantation Center
Surgical Director, Renal Transplantation Program
Biographical Sketch
David Goldfarb, MD, has been at Cleveland Clinic for more than 20 years. Following graduation in 1985 from Temple University School of Medicine, he completed his residency and an AFUD scholarship at Cleveland Clinic. He developed clinical expertise in renal transplantation, kidney tumor surgery and benign prostate surgery. In 2003, he became the Surgical Director of the Renal Transplantation Program at the Glickman Urological Institute.
He is distinguished as a two-time appointee to the American Board of Urology Exam Committee. He was the inaugural President of the Paired Donation Consortium, a non-profit organization dedicated to provide paired donation to incompatible renal transplant patients. Dr Goldfarb recently completed a term as president of the Urological Society for Transplantation and Renal Surgery.
Dr Goldfarb has published more than 80 scientific papers and 20 book chapters. He lectures worldwide on various aspects of renal transplantation.
Education & Fellowships
| Medical School: | Temple University School of Medicine, Philadelphia, PA |
|
| Residency: | Cleveland Clinic, Urology, Cleveland, OH |
| Residency: | Cleveland Clinic, General Surgery, Cleveland, OH |
| Other Education: | (Undergraduate) The University of Montana, Missoula, MT |
Certifications
Specialty Interests
Renal transplantation.
Awards & Honors
- George & Grace Crile Traveling Fellowship Award, 1990
- American Foundation Urologic Disease Scholarship, 1990-1992
- Pfizer Scholar in Urology Award,1996
Professional Memberships
- American Urological Association
- American College of Surgeons
- American Society of Transplant Surgeons
- Urological Society for Transplant And Vascular Surgery
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists report if they have any collaborations with the pharmaceutical or medical device industries as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/30/2008, Dr. Goldfarb has reported no financial relationship with industry that is applicable to this listing. Patients should feel free to contact their doctor about relationships with industry and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
